News and Insights

M&A Strategy and Integration

Healthcare’s ‘Bigness’ Solution Was A Half-Truth

Forbes

A decade ago, pundits were beating the drum about “bigness,” saying things like: “You need to get bigger.” “You need to have scale.” “You need local market dominance to matter.” Similarly, healthcare leaders were told: “This is the only way to get to value.” “This is the only way to…

A Recipe for Post-Merger Success: Building Organizational Alignment

With articles about health system mergers and acquisitions becoming a regular fixture in business publications, why is it that anticipated benefits of mergers remain so elusive?  Despite countless hours of time spent on identifying the “perfect” partner or target, conducting due diligence, surviving hard fought negotiations, and executing exquisitely detailed…

To Remain Independent or Not? That is the Question

Provider consolidation has been accelerating at a rapid clip in the healthcare industry in recent years.  In fact, the pace has increased 14% on average in each of the last seven years, impacting all delivery system types.1 “Mega-mergers” involving combined assets of 2B or more are growing more frequent, too. These…

The Affordable Care Act’s Impact on Innovation in Biopharma

BioPharm International

The Affordable Care Act (ACA) has elicited intense national debate and sent biopharmaceutical companies scrambling to understand how their business model, including its ability to innovate, will change as healthcare reform moves forward.  Within this uncertain market, what is obvious is that the industry is in the midst of significant…

Creating a Framework for Accountable Care: Ensuring Product Value

Jefferson School of Population Health

The U.S. healthcare system is currently undergoing what will ultimately be a radical transformation, driven by unsustainable cost increases, increasing regulation, and shifting power relationships among payers, providers, physicians, and patients.  Technology advances are accelerating the pace of innovation, while rising costs and demands for affordable healthcare and greater transparency…

Value Added Services: What It Takes to Do It Right

Numerof Brief

As a strategy to offset declining revenues, companies are testing a variety of initiatives focused on creating value added services (VAS) for drugs and medical devices. Disease management programs have been tried before by product manufacturers with limited success. This new wave differs from prior experiments in that it leverages…